Results 171 to 180 of about 510,329 (306)

Basal Metabolic Requirements, Biomarkers of Cardiometabolic Health, and Anthropometric Measures of Obesity in Women and Men With Restricted Growth Conditions

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Population‐specific thresholds have not been defined for the levels of adiposity and systemic biomarkers that predict chronic health risks in people with restricted growth conditions. Here, anthropometric measures of adiposity, basal metabolic requirements, and fasted blood samples were obtained from adults with restricted growth (age 41 ± 14 ...
Lucy H. Merrell, Harry A. Smith, Harriet A. Carroll, Yung‐Chih Chen, Dylan Thompson, Javier T. Gonzalez, Greg Atkinson, James A. Betts   +7 more
wiley   +1 more source

Biotin Interference in Thyroid Function Tests. [PDF]

Dtsch Arztebl Int
Rußwurm M, Wild J, Göbel J.
europepmc   +1 more source

An OGT Missense Variant With Impaired Enzyme Activity in a Child With Severe Developmental Delay and Hepatoblastoma

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT O‐GlcNAc transferase (OGT) and its antagonist O‐GlcNAcase (OGA) regulate protein O‐GlcNAcylation, a highly conserved post‐translational modification involved in metabolic sensing. Pathogenic variants in the OGT gene cause an X‐linked congenital disorder of glycosylation (OGT‐CDG) presenting developmental delay, hypotonia, intellectual ...
Alfonso Manuel D'Alessio, Huijie Yuan, Leandro Raul Soria, Sara Basse Hansen, Iolanda Boffa, Paola Arena, Benedetta Attianese, Maureen. O'Sullivan, Noelle Cullinan, Lewis Pang, Daan Marinus Ferdinand van Aalten, Nicola Brunetti‐Pierri, Sally Ann Lynch   +12 more
wiley   +1 more source

Schizophrenia Genetics Modulates Clinical Depressive Features

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.
ABSTRACT Schizophrenia (SCZ) genetic liability, quantified by polygenic scores (PGS), may influence clinical phenotypes in major depressive disorder (MDD). We investigated the effect of the SCZ‐PGS derived from the latest SCZ genome‐wide association study (GWAS) on MDD symptom severity, comorbidities, and treatment outcomes.
Alessandro Serretti, Daniel Souery, Siegfried Kasper, Joseph Zohar, Stuart Montgomery, Panagiotis Ferentinos, Dan Rujescu, Raffaele Ferri, Giuseppe Fanelli, Chiara Fabbri, Raffaella Zanardi, Francesco Benedetti, Bernhard T. Baune, Julien Mendlewicz   +13 more
wiley   +1 more source

Correction: Associations of serum keratin 1 with thyroid function and immunity in Graves' disease. [PDF]

PLoS One
Cheng CW, Fang WF, Lin JD.
europepmc   +1 more source

Effect of Interferon-Beta on Thyroid Function in Patients of Chronic Hepatitis C without Preexisting Autoimmune Thyroid Disease.

, 1996
Yukihiro Nagai, KENSOU OHSAWA, Yasuhiko Ieki, Kenichi Kobayashi   +3 more
openalex   +2 more sources

Genomics Review of Selective RET Inhibitors Sensitivity in Thyroid Cancer Clinical Trials

American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.
ABSTRACT RET gene is a driver of thyroid cancer (TC) tumorigenesis. The incidence of TC has increased worldwide in the last few decades, both in medullary and follicular‐derived subtypes. Several drugs, including multikinase and selective inhibitors, have been explored.
Sara Gil‐Bernabé, Lucía García‐DeLaFuente, Alejandro García‐Álvarez, Ginesa García‐Rostán, Jaume Capdevila, Jorge Hernando   +5 more
wiley   +1 more source

The role of the primary cilium in thyroid function and dysfunction with implications for thyroid disease. [PDF]

Histochem Cell Biol
Martín-Lacave I, Vázquez-Román V, Pérez-Fernández B, Fernández-Santos JM.   +3 more
europepmc   +1 more source

Interconnection between thyroid hormone signalling pathways and parvovirus cytotoxic functions [PDF]

, 1993
Jean-Marc Vanacker, Vincent Laudet, Guillaume Adelmant, D. Stéhelin, Jean Rommelaere   +4 more
openalex   +1 more source

A systematic review of transgender male rodent model methodology

Animal Models and Experimental Medicine, EarlyView.
Summary of successful transgender male rodent model methods. Testosterone enanthate or cypionate injected SC or IM once per week at 18 mg/kg in mice or 3 mg/kg in rats should effectively match naive male testosterone levels of their respective species.
Kai Robertson, Dylan Lane, Daniel Donner, Jason Peart, Eugene du Toit   +4 more
wiley   +1 more source